首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 62 毫秒
1.
目的 观察和比较氟比洛芬酯与帕瑞昔布钠用于腹腔镜手术后镇痛的效果.方法 择期全麻下行腹腔镜手术患者90例随机分为三组,全麻诱导和维持方法 相同,手术结束前15min,A组(对照组)不用任何镇痛药物;F组(氟比洛芬酯组)静注氟比洛芬酯1 mg/kg;P组(帕瑞昔布钠组)静注帕瑞昔布钠40 mg.记录三组术后1h、2h、4h、8h、12h的VAS评分及观察恶心、呕吐、嗜睡、呼吸抑制、瘙痒等不良反应的发生情况.结果 F组和P组患者术后各时点的VAS评分显著低于A组(P<0.01),P组患者术后各时点的VAS评分明显低于F组(P<0.05).结论 氟比洛芬酯与帕瑞昔布钠均可有效的减轻腹腔镜手术后的疼痛,且不良反应少,帕瑞昔布钠的镇痛效果优于氟比洛芬酯.  相似文献   

2.
目的 比较肛肠和直肠手术后帕瑞昔布钠与氟比洛芬酯的镇痛效果.方法 肛肠和直肠手术患者40例,随机分为两组,A组(n=20)手术结束前静脉注射帕瑞昔布40 mg,B组(n=20)手术结束前静脉注射氟比洛芬酯1 mg/kg,采用VAS评分观察术后镇痛效果与不良反应.结果 A组较B组VAS评分低(P<0.05),B组恶心、呕...  相似文献   

3.
目的 比较帕瑞昔布钠与氟比洛芬酯用于耳鼻喉科手术后的镇痛效果.方法 全麻下耳鼻喉科手术患者60例,分为A、B、C组(每组20例),手术结束前10~20min,A组静注生理盐水10ml,B组静注帕瑞昔布钠40mg,C组静注氟比洛芬酯100mg.观察术后2、4、8、12和24h VAS评分,术后24h镇痛的补救措施、满意度和不良反应.结果 与A组相比,B组和C组术后2、4、8和12h VAS评分降低(P<0.05),与B组相比,C组在各时间点差异无统计学意义(P>0.05),术后24h满意度提高(P<0.05),3组不良反应发生差异无统计学意义(P>O.05).结论 术毕前静注帕瑞昔布钠40mg和氟比洛芬酯100mg可以减轻耳鼻喉科病人术后疼痛.  相似文献   

4.
目的评价帕瑞昔布钠用于重症肌无力患者胸腺切除术后镇痛的效果。方法选择行胸腺切除术的重症肌无力患者157例,分为曲马朵组(51例,术后给予肌肉注射曲马朵1.02.0 mg·kg-1)、氟比洛芬酯组(53例,术后予以静脉缓慢滴注0.82.0 mg·kg-1)、氟比洛芬酯组(53例,术后予以静脉缓慢滴注0.81.0 mg·kg-1氟比洛芬酯)和帕瑞昔布钠组(53例,术后予以静脉缓慢滴注0.61.0 mg·kg-1氟比洛芬酯)和帕瑞昔布钠组(53例,术后予以静脉缓慢滴注0.61.0 mg·kg-1帕瑞昔布钠),对3组患者术后1、2、6、12、24 h的静息及运动视觉模拟评分(VAS)、平均动脉压(MAP)、心率(HR)、呼吸频率(RR)、血氧饱和度(SpO2)及不良反应发生率进行比较分析。结果氟比洛芬酯组及帕瑞昔布钠组术后1、2、6、12、24 h的静息及运动VAS评分、MAP、HR、RR显著低于曲马朵组,差异有统计学意义(P<0.05)。帕瑞昔布钠组患者术后1、2、6、12、24 h的静息及运动VAS评分均显著低于氟比洛芬酯组(P<0.05)。氟比洛芬酯组及帕瑞昔布钠组的不良反应发生率均显著低于曲马朵组(P<0.05),且帕瑞昔布钠组的不良反应发生率显著低于氟比洛芬酯组(P<0.05)。结论重症肌无力患者胸腺切除术后采用帕瑞昔布钠进行镇痛,其镇痛时效显著优于氟比洛芬酯及曲马朵,且镇痛药物剂量小,术后不良反应率低。  相似文献   

5.
康凯  王玥  李杉  刘野  赵国胜  徐铭军 《北京医学》2016,(11):1160-1163
目的 比较氟比洛芬酯和帕瑞昔布钠对老年妇科腹腔镜手术后疼痛及认知功能的影响.方法 择期全麻气管插管下行腹腔镜手术的老年女性患者80例,随机分为4组:F1组全麻插管后给予氟比洛芬酯50 mg,F2组术毕前30 min给予氟比洛芬酯50 mg,P1组全麻插管后给予帕瑞昔布钠40 mg,P2组术毕前30 min给予帕瑞昔布钠40 mg,每组20例.所有患者均采用常规麻醉诱导及术中维持,术后连接相同配方的静脉镇痛泵转入麻醉恢复室.记录各时点的HR、MAP,记录术后6h、12h及24 h的VAS疼痛评分以及各组拔管后10 min的Ramsay镇静评分和Riker-SAS躁动评分,记录术前,术后24 h、72 h的认知功能障碍情况.结果 术后6h的VAS评分F2和P2组明显低于F1和P1组(P<0.05),P1和P2组的VAS评分在术后12h低于F1和F2组,4组患者术后24 h的VAS评分差异无统计学意义(P<0.05).与术前24 h比较,4组患者术后24 h的MMSE评分均下降,差异有统计学意义(P< 0.05);与F2和P2组比较,F1和P1组24 h时MMSE评分升高,术后72 h内POCD发生率较低(P<0.05).结论 两种非甾体类镇痛药均可以降低POCD的发生率,在插管后给予帕瑞昔布钠用于术后镇痛更趋于合理.  相似文献   

6.
李德维  曾炼坤  张艳  曹阳 《海南医学》2011,22(16):55-56
目的探讨妇科腹腔镜术后单次静脉注射氟比洛芬酯和帕瑞昔布的术后镇痛效果。方法拟行择期全麻下行妇科腹腔镜手术成年女性患者45例,随机分成氟比洛芬酯组(F组)、帕瑞昔布组(P组)和生理盐水组(C组),每组15例。麻醉诱导用药为丙泊酚2mg/kg,舒芬太尼0.5μg/kg和罗库溴铵0.6mg/kg。术中以七氟烷吸入维持镇静,根据需要静脉注射罗库溴铵0.3mg/kg维持肌松和舒芬太尼0.2μg/kg维持镇痛。手术结束前15min分别静脉注射氟比洛芬酯50mg、帕瑞昔布40mg和生理盐水5ml。观察患者的睁眼时间、拔管时间、术后停留复苏室时间。记录患者术后1h、3h、6h、12h和24h的VAS评分。结果 F组和P组各时段VAS评分值均低于C组(P〈0.01和P〈0.05),术后24hF组VAS评分高于P组(P〈0.05)。各组术后不良反应发生率差异无统计学意义(P〉0.05)。结论妇科腹腔镜术结束前单次静脉注射氟比洛芬酯和帕瑞昔布均可显著减轻术后急性疼痛,氟比洛芬酯在术后3h内镇痛效果更好,帕瑞昔布维持镇痛的时间更长。  相似文献   

7.
目的观察帕瑞昔布钠治疗周围血管患者术后疼痛的有效性。方法择期行大隐静脉高位结扎剥脱术的患者120例,年龄40~60岁,ASAⅠ~Ⅱ级,随机分为帕瑞昔布钠组和对照组,每组60例。两组患者均选择连续硬膜外麻醉,帕瑞昔布钠组在硬膜外穿刺前经静脉给予帕瑞昔布钠40 mg,间隔12 h再次静脉给予帕瑞昔布钠40 mg,对照组给予等量生理盐水。记录患者术后12 h和24 h的VAS评分,两组患者均在要求术后止痛时,先行VAS评分,3分以上的给予杜冷丁1 mg.kg-1,记录术后12 h和24 h两组患者的VAS评分,两组患者术后需要辅助镇痛发热的例数,以及观察期间恶心呕吐等不良反应的发生情况。结果两组比较,帕瑞昔布钠组12 h和24 h VAS评分均低于对照组,仅12 h点两组VAS评分差异有统计学意义(P〈0.05)。帕瑞昔布钠组无术后辅助镇痛的患者,3例发生术后恶心呕吐,而对照组在术后辅助镇痛的发生率和恶心呕吐的发生率上都远远高于帕瑞昔布钠组,差异均有统计学意义(P〈0.05)。结论帕瑞昔布钠用于周围血管手术患者术后镇痛效果确切,不良反应少,具有广泛的运用前景。  相似文献   

8.
帕瑞昔布钠在后路脊柱术后镇痛的疗效观察   总被引:2,自引:1,他引:1  
目的 探讨帕瑞昔布钠在脊柱后路手术患者术后镇痛的临床疗效.方法 全麻下行后路脊柱手术患者80例,随机分为帕瑞昔布钠组和安慰剂组,双盲对照观察.镇痛方法:手术结束所有患者给予背景镇痛液吗啡1.0 mg/mL,,单次给药剂量2 ml后,帕瑞昔布钠组(40例):静脉注射帕瑞昔布钠40 mg,安慰剂组(40例)静脉注射生理盐水2 ml;术后24、48h予相同剂量重复给药.观察VAS疼痛评分、患者满意度和不良反应.结果 与安慰剂组相比,帕瑞昔布钠组术后6、12、24、48h四个时间点VAS评分明显小于安慰机组(P<0.05).两组满意率和不良反应发生率差异无统计学意义.结论 脊柱后路术后短期应用帕瑞昔布钠镇痛,可为患者提供良好的镇痛效果.  相似文献   

9.
麦亚强 《实用全科医学》2010,8(7):858-858,860
目的观察帕瑞昔布钠在鼻内窥镜手术的超前镇痛效果。方法择期全麻下鼻内窥镜手术患者60例,随机分成帕瑞昔布钠超前镇痛组Ⅰ组(30例)与安慰剂对照组Ⅱ组(30例)。Ⅰ组于麻醉诱导前静注帕瑞昔布钠40mg,Ⅱ组于麻醉诱导前静脉注射生理盐水2ml。所有患者均采用持续静脉泵注异丙酚复合瑞芬太尼全凭静脉麻醉下完成手术。分别记录术后2,4,6,12,24h每组患者的视觉模拟疼痛评分(VAS)和不良反应。结果术后24h各时点内Ⅰ组的VAS疼痛评分均明显优于Ⅱ组(P〈0.05)。两组均未见严重不良反应。结论帕瑞昔布钠超可以为鼻内窥镜手术提供有效、安全的超前镇痛。  相似文献   

10.
目的:研究帕瑞昔布钠在腹腔镜胆囊切除术术后早期疼痛治疗中的临床效果及安全性.方法:将60例入住我院行择期腹腔镜胆囊切除手术的患者(ASA分级Ⅰ~Ⅱ级),随机分为两组,每组30例.A组手术结束前30 min静注帕瑞昔布钠40 mg/5ml,B组为对照组,于手术结束前30 min静注生理盐水5 ml.若患者术后不能耐受疼痛,单次静脉注射盐酸曲马多1.5 mg/kg.记录2组患者静注帕瑞昔布钠或生理盐水后2、4、6、8、12、24 h的疼痛视觉模拟评分(VAS)、术后24 h曲马多用量及用药次数,并观察呼吸抑制、恶心、呕吐及凝血功能障碍等不良反应的发生率以及清醒时的躁动情况.结果:与对照组相比,帕瑞昔布钠组术后VAS评分降低(P<0.05),术后24 h盐酸曲马多的用量及用药次数减少(P<0.05),不良反应发生率降低(P<0.05).结论:帕瑞昔布钠预先给药用于腹腔镜胆囊切除术术后早期镇痛效果确切,同时可减少术后患者躁动的发生,且不良反应少.  相似文献   

11.
Objective: To evaluatel the value of D-dimers in patients with acute aortic dissection (AAD). Methods: This study consisted of 16 patients with AAD and 27 non-AAD patients. Serum D-dimets were measured by Sta-Liatest D-DI immunoturbidimetric assay. Results: D-dimer level was higher (P < 0.001) in patients with AAD(7.91 ± 5.52 μg/ml) than that in non- AAD group(1.57±1.24 μg/ml). D-dimer was positive (>0.4 μg/ml) in all patients with AAD and in 10 control group patients (37%). Among patients with acute AAD, D-dimers tended to be higher in Stanford A than in Stanford B (8.67 ± 4.31 μg/ml vs. 3.24±1.27 μg/ml, P <0.01). D-dimer values tended to be higher in more extended disease(3.84 ± 1.65 μg/ml, 8.57 ± 3.58 μg/ml and 11.87 ± 5.69 μg/ml in thoracic aorta, thoracic and abdominal aorta, thoracic and abdominal aorta and iliacal arteries, respectively, P < 0.05 for both 8.57 ± 3.58 and 11.87 ± 5.69 vs. 3.84 ± 1.65 ). Including the control group into the analysis, we found a sensitivity of 100%, a negative predictive value of 100%, and a specificity of 66% and a positive predictive value of 64% for D-dimer in diagnosis of AAD in our patients with suspected AAD. Conclusion: D-dimer was elevated in patients with AAD. A negative D-dimer test result could be useful in excluding AAD.  相似文献   

12.
Objective: To set up a simple and reliable rat model of combined liver-kidney transplantation. Methods: SD rats served as both donors and recipients. 4℃ sodium lactate Ringer's was infused from portal veins to donated livers,and from abdominal aorta to donated kidneys, respectively. Anastomosis of the portal vein and the inferior vena cava (IVC) inferior to the right kidney between the graft and the recipient was performed by a double cuff method, then the superior hepatic vena cava with suture. A patch of donated renal artery was anastomosed to the recipient abdominal aorta. The urethra and bile duct were reconstructed with a simple inside bracket. Results: Among 65 cases of combined liver-kidney transplantation, the success rate in the late 40 cases was 77.5%. The function of the grafted liver and kidney remained normal. Conclusion: This rat model of combined liver-kidney transplantation can be established in common laboratory conditions with high success rate and meet the needs of renal transplantation experiment.  相似文献   

13.
Objective To observe blood pressure change with age in salt-sensitive teenagers whose salt sensitivity were determined by repeated testing.Methods Salt sensitivity was determined through intravenous infusion of normal saline combined with volume-depletion by oral diuretic furosemide in 55 teenagers. After five years, salt sensitivity was re-examined and subject blood pressure was followed up. Blood pressure changes in salt-sensitive teenagers were compared to that of non-salt sensitive teenagers over five years.Results After 5 years, the repetition rate of salt sensitivity determined by intravenous saline loading is 92.7%. In teenagers with salt sensitivity on the baseline, both the systolic blood pressure increments and increment rates were much higher than non-salt sensitive teenagers (12.7±12.1 mmHg vs. 2.8±5.2 mmHg, P< 0.01; 12.2%± 12.0% vs. 2.5% ±4.4%, P< 0.001,respectively). There was a similar trend for diastolic blood pressure (8.4 ± 6.4 mmHg vs. 3.7 ± 6.4 mmHg, P = 0.052; 13.2% ±10.6 % vs. 6.8%± 10.1%, P = 0.053, respectively).Conclusions Salt sensitivity determined by intravenous saline loading showed good reproducibility. Blood pressure increments with age were much higher in salt-sensitive teenagers than non-salt sensitive teenagers, especially in terms of systolic blood pressure.  相似文献   

14.
目的:评价使用安心颗粒对急诊经皮冠状动脉介入术(PPCI)术后生活质量的影响.方法:将160例接受PPCI的急性ST段抬高型心肌梗死患者随机分为安心颗粒组(术前顿服安心颗粒8.8g,术后安心颗粒4.4 g/次,每日2次)和对照组(仅接受基础药物治疗).所有患者均服用阿司匹林、氯吡格雷和阿托伐他汀.分别在入院时、出院前1d、出院后180 d时,应用心肌梗死多维度量表(MIDAS)、中文版SF-36评价量表对患者生活质量评分.并观察术后30 d以内的出血并发症、血小板减少症发生情况.结果:入院时和出院前1d,两组患者的心肌梗死MIDAS、SF-36量表评分比较无差异(P>0.05);出院后180 d时,与对照组比较,安心颗粒组MIDAS、SF-36评分明显减低(P<0.05);组内与入院时比较,两组出院前1d、出院后180 d时,MIDAS、SF-36评分均降低(P<0.05).两组患者在随访期间均无大量出血、少量出血、重度和极重度血小板减少症发生,安心颗粒组有4例、对照组有7例发生不明显出血(P>0.05).两组发生轻度血小板减少症的患者数比较无差异(P>0.05).结论:PPCI使用安心颗粒,能改善急性ST段抬高型心肌梗死患者的生活质量,且不增加出血风险.  相似文献   

15.
Objective:To investigate the influences of urapidil and nicardipine on rabbit sinus function,atrio-ventricular node function and hemodynamics.Methods:Thirty-two Angora's rabbits were selected and randomly divided into four groups.U1 group:urapidil 0.25 mg/kg;U2 group:urapidil 0.5 mg/kg;N1 group:nicardipine 10 μg/kg;N2 group:nicardipine 20 μg/kg.All these medicine were administrated within 30 seconds.Measurements were taken before and after the administration of urapidil or nicardipine for the following data:mean blood pressure(MAP),heart rate(HR),sino-atrial conduction time(SACT),maximal sinoatrial recovery time(SNRTmax)corrected sinus node recovery time(CSNRT),index of sinus node recovery time(SNRTI),Wenckebach A-V conduction frequency (WB),and P-R interval.Results:Significant MAP and HR changes were identified in all of the four groups before and after administration of both urapidil and nicardipine.No significant changes could be found in the rest of the parameters.Intergroup analysis showed that SACT and CSNRT of N1 and N2 groups were shorter than those of the U2 group(P<0.01);the MAP decreased(P<0.01)and the HR increased drastically(P<0.01).Conclusions:Neither urapidil(0.25 mg/kg,0.5 mg/kg)nor nicardipine(10μg/kg,20μg/kg)has any significant influence on rabbit sinus function or rabbit atrio-ventricular node function.Nicardipine could be a better choice than urapidil for parafunctional sinus node patients.  相似文献   

16.
Objective:To investigate the gene expression of osteoprotegerin(OPG) and osteoclast differentiation factor(ODF) in the bone tissue of patients with hip fracture due to osteoporosis. Methods:OPGmRNA and ODFmRNA in the bone tissue in 50 cases of osteoporosis sufferers(over 50 years old) with hip fracture(Observer Group) and 30 cases of hip facture sufferers with no osteoporosis(Control group) were analyzed with the Semi-Quantitative RT-PCR method. Results:The mRNA expressed of ODF, OPG were both high in the patients with hip fracture. In the control group, the expression of OPG mRNA was observed, while the expression of ODF mRNA was very slight. Conclusion:Aged patients contained all signals including OPG, ODF that are essential for inducing osteoclastogenesis and promoting bone resorption.  相似文献   

17.
Objective:To investigate the clinical features, pathological characteristics and immunophenotype of solid-pseudopapillary tumor of the pancreas(SPTP). Methods:Nine surgically treated cases of SPTP were retrospectively reviewed. Hematoxylin and Eosin(HE) staining and immunohistochemical staining were used to analyze all cases, and the general clinical data was collected. Results:Six patients were asymptomatic except for a palpable mass. Two patients complained of vague-epigastric pain. One patient appeared jaundice. The tumor was encapsulated and solid tissues alternately with cystic tissues. Histologically, the histological structure of solid portion was pseudopapillary with a fibrovascular core. Tumor cells were uniform and medium-sized which were arranged in sheets ets or nests or pseudopapillary patterns. Immunohistochemical studies demonstrated that SPTP proved positive in vimentin(9/9 cases), AAT(9/9 cases), NSE(9/9 cases), ACT(7/9 cases), CK20(2/9 cases), CgA(1/9 cases), S-100(3/gcases), PR(4/gcases), Syn(3/9 cases) and CD56(5/9cases), negative in CEA and ER. Conclusion:SPTP is a tumor predominantly occurring in young women frequently without special symptoms. This tumor has various characteristical histological patterns with different immunophenotype.  相似文献   

18.
Objective:To probe into the influence of changes of ovarian hormones on the pathogenesis of the specific sub-type premenstrual syndrome(PMS)and reveal partial microcosmic mechanisms of adverse flow of liver-qi.Methods:Estradiol(E2)and progesterone(P)levels in serum were determined at different phases of menstrual cycle by radioimmunoassay.Results:In the group of PMS with adverse flow of liver-qi.the secretive peak value Of E2 and P at the follicular phase significantly decreased,and the secretive peak value at the luteal phase did not come into being.Conclusions:Low E2 and P secretive peak at the follicular phase and absence of secretive peak at the luteal phase is one of the microcosmic mechanisms of PMS with adverse flow of liver-qi.One of the pathophysiologic mechanisms of specific sub-type PMS is probably the continuous low level of E2and P.  相似文献   

19.
Real-time three-dimensional echocardiography (RT3DE)is a new ultrasound technique that enables dynamic threedimensional visualization and quantification of the heart in real time. Investigation of feasibility and methodology of RT3DE in determining left ventricular (LV) and right ventricular (RV) volumes, RT3DE was performed in 35 normal adults using Philips SONOS 7500 system with a 2-4 MHz matrix array transducer. The 60°×60° "pyramid" volume database was obtained and analyzed on a TomTec echo workstation. Both LV and RV volumes were calculated with four 3DE methods (i.e. apical 2, 4, 8, and 16-plane) through manually tracing ventricular endocardial borders in end diastole and end systole. Stroke volumes were then calculated. LV volume was also measured by 2DE Simpson's rule using GE VIVID 7 ultrasound machine.  相似文献   

20.
Increasing maternal age is the only etiological factor unequivocally linked to Down's syndrome in humans. The occurrence rate of newborns with Down's syndrome is about 1/220 in women over 35 years old. However, the occurrence rate in embryos fertilized in vitro, of the elder woman is unclear. Using FISH we screened the number of chromosome 21 in preimplanted embryos of 5 elderly women (average age, 38.4 years) to study the feasibility and necessity of screening trisomy 21 in embryos in patients over 35 years old at the in vitro fertilization (IVF) center.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号